Close Menu

marketing agreement

The firms will co-develop a new tissue-based imaging and analysis solutions for protein biomarkers.

Seahorse Extracellular and Flux Analyzers provide a kinetic method of measuring mitochondrial respiration and glycolysis, the two major energy-producing pathways, in living cells in a microplate, the company said.

Shimadzu's LC and GC systems sold in the US will come with Phenomenex columns, under the terms of the deal.

The deal will take Novartis into the blood genotyping market.

LabCorp will be XDx's preferred third-party, non-hospital provider for phlebotomy and specimen processing for all XDx AlloMap molecular expression tests conducted in North America.

The agreement follows yesterday's announcement of a similar pact with Ion Torrent.

As part of the deal, FIND will have rights to sell the HIV test, as well as Cepheid's Xpert chlamydia and gonorrhea tests, which will be sold at a discount to the public and the not-for-profit sector in some countries.

Ion Torrent will offer software from Partek and DNAStar directly through its online store, and it has inked a service and support deal with BioTeam for the Ion Torrent Server and Torrent Suite Software.

Caris will exclusively offer Signal's Myeloma Prognostic Risk Signature, or MyPRS, test to community-based hematologists and medical oncologists across the US.

The instruments were acquired just three months ago by Cellectis from Cyto Pulse Sciences.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.